Pharmacokinetics of lipoyl vildagliptin, a novel dipeptidyl peptidase IV inhibitor after oral administration in rats

By Wang X.   Zhang D.   Xu W.   Liu H.   Wang W.  

Xenobiotica, Vol. 40, Iss. 10, 2010-10 ,pp. : 707-712

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and metabolism of [¹⁴C]anagliptin, a novel dipeptidyl peptidase-4 inhibitor, in humans

By Furuta Shinji   Smart Clair   Hackett Andrew   Benning Rajdeep   Warrington Steve  

Xenobiotica, Vol. 43, Iss. 5, 2013-05 ,pp. : 432-442

Informa Healthcare

Access to resources Recommend Favorite

Disposition and metabolism of almotriptan in rats, dogs and monkeys

By Aubets J.   Cardenas A.   Salva M.   Jansat J. M.   Martinez-Tobed A.   Palacios J. M.  

Xenobiotica, Vol. 36, Iss. 9, 2006-09 ,pp. : 807-823

Informa Healthcare

Access to resources Recommend Favorite

Absorption, metabolism and excretion of [¹⁴C]gemigliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans

By Kim Namtae   Patrick Lorna   Mair Stuart   Stevens Lloyd   Ford Gill   Birks Vicky   Lee Sung-Hack  

Xenobiotica, Vol. 44, Iss. 6, 2014-06 ,pp. : 522-530

Informa Healthcare

Access to resources Recommend Favorite

Improved Glucose Tolerance via Enhanced Glucose-Dependent Insulin Secretion in Dipeptidyl Peptidase IV-Deficient Fischer Rats

By Nagakura T.   Yasuda N.   Yamazaki K.   Ikuta H.   Yoshikawa S.   Asano O.   Tanaka I.  

Biochemical and Biophysical Research Communications, Vol. 284, Iss. 2, 2001-06 ,pp. : 501-506

Elsevier

Access to resources Recommend Favorite